Paper36979684
The Usefulness of Nanotechnology in Improving the Prognosis of Lung Cancer.
Bordeianu G and 9 others. Biomedicines, 2023. Cited by 2 papers, by iCite.
Cite this record
ConductScience Library. The Usefulness of Nanotechnology in Improving the Prognosis of Lung Cancer. Papers, record 36979684. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36979684
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References167
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 34820358 | PPy@Fe3O4 Nanoparticles Inhibit Tumor Growth and Metastasis Through Chemodynamic and Photothermal Therapy in Non-small Cell Lung Cancer. | Front Chem | 2021 | https://conductscience.org/library/papers/34820358 | PubMed |
| 2 | 35547502 | Engineering docetaxel-loaded micelles for non-small cell lung cancer: a comparative study of microfluidic and bulk nanoparticle preparation. | RSC Adv | 2018 | https://conductscience.org/library/papers/35547502 | PubMed |
| 3 | 29219050 | Long Circulating Polymeric Nanoparticles for Gene/Drug Delivery. | Curr Drug Metab | 2018 | https://conductscience.org/library/papers/29219050 | PubMed |
| 4 | 21571619 | Albumin-bound paclitaxel: the benefit of this new formulation in the treatment of various cancers. | J Chemother | 2011 | https://conductscience.org/library/papers/21571619 | PubMed |
| 5 | 21447361 | Dual-ligand modification of PEGylated liposomes shows better cell selectivity and efficient gene delivery. | J Control Release | 2011 | https://conductscience.org/library/papers/21447361 | PubMed |
| 6 | 16914222 | Cationic lipids, lipoplexes and intracellular delivery of genes. | J Control Release | 2006 | https://conductscience.org/library/papers/16914222 | PubMed |
| 7 | 31234290 | Protein Adsorption: A Feasible Method for Nanoparticle Functionalization? | Materials (Basel) | 2019 | https://conductscience.org/library/papers/31234290 | PubMed |
| 8 | 35958515 | Mitochondria-targeting polydopamine-coated nanodrugs for effective photothermal- and chemo-synergistic therapies against lung cancer. | Regen Biomater | 2022 | https://conductscience.org/library/papers/35958515 | PubMed |
| 9 | 21657258 | Carbon nanotubes induce malignant transformation and tumorigenesis of human lung epithelial cells. | Nano Lett | 2011 | https://conductscience.org/library/papers/21657258 | PubMed |
| 10 | 32478055 | Strategies to Obtain Encapsulation and Controlled Release of Small Hydrophilic Molecules. | Front Bioeng Biotechnol | 2020 | https://conductscience.org/library/papers/32478055 | PubMed |
| 11 | 33277608 | Engineering precision nanoparticles for drug delivery. | Nat Rev Drug Discov | 2021 | https://conductscience.org/library/papers/33277608 | PubMed |
| 12 | 16862189 | Drug penetration in solid tumours. | Nat Rev Cancer | 2006 | https://conductscience.org/library/papers/16862189 | PubMed |
| 13 | 29453547 | Using of Quantum Dots in Biology and Medicine. | Adv Exp Med Biol | 2018 | https://conductscience.org/library/papers/29453547 | PubMed |
| 14 | 34866166 | Nanoparticles for Cancer Therapy: Current Progress and Challenges. | Nanoscale Res Lett | 2021 | https://conductscience.org/library/papers/34866166 | PubMed |
| 15 | 29512452 | Formulations, Pharmacodynamic and Clinical Studies of Nanoparticles for Lung Cancer Therapy - An Overview. | Curr Drug Metab | 2018 | https://conductscience.org/library/papers/29512452 | PubMed |
| 16 | 12711172 | Optimization of the preparation process for human serum albumin (HSA) nanoparticles. | Int J Pharm | 2003 | https://conductscience.org/library/papers/12711172 | PubMed |
| 17 | 31514848 | Electrochemical biosensors for the detection of lung cancer biomarkers: A review. | Talanta | 2020 | https://conductscience.org/library/papers/31514848 | PubMed |
| 18 | 14644890 | Test performance of positron emission tomography and computed tomography for mediastinal staging in patients with non-small-cell lung cancer: a meta-analysis. | Ann Intern Med | 2003 | https://conductscience.org/library/papers/14644890 | PubMed |
| 19 | 32003260 | Solid lipid nanoparticles: a review on recent perspectives and patents. | Expert Opin Ther Pat | 2020 | https://conductscience.org/library/papers/32003260 | PubMed |
| 20 | 21723891 | Inorganic nanoparticles for cancer imaging and therapy. | J Control Release | 2011 | https://conductscience.org/library/papers/21723891 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 38333709 | Tumor-derived extracellular vesicle drug delivery system for chemo-photothermal-immune combination cancer treatment. | iScience | 2024 | https://conductscience.org/library/papers/38333709 | PubMed |
| 38321901 | Role of Nanoformulations in the Treatment of Lung Cancer. | Recent Pat Nanotechnol | 2025 | https://conductscience.org/library/papers/38321901 | PubMed |
Genes23
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36979684
GET https://conductscience.org/api/papers/v1/36979684/references?page=2